Celadrin is a natural compound composed of esterified fatty acid carbons (EFACs) and other active synergists. It can be formulated into both pill and cream forms. Published research has shown that people taking both forms of Celadrin had significant improvement in knee range of motion and decreased knee pain, without side effects.
Dean Mosca, President of PNI, said "Celadrin works faster than other natural ingredients and doesn't have the side effects of drugs. Since it addresses a wide range of joint, muscle, and tendon-related ailments, we think it is the perfect new product for the $22 billion joint health market."
Bill Spencer, President of Imagenetix, added, "Celadrin is effective and easy to use, separately, or in formulations with other compounds. We're excited about working with Proprietary Nutritionals to help make it a household brand."
In a double blind, placebo-controlled study of people with knee pain conducted at the University of Connecticut, researchers found that 100% of patients using Celadrin topical cream were able to move faster, with less pain when climbing stairs or rising from a chair. This data, along with previous research data on the Celadrin pill, has been published in the Journal of Rheumatology.
Celadrin is manufactured in the United States under good manufacturing practices (GMPs) and undergoes a proprietary process that enables it to penetrate the cell membrane for maximum efficacy.
Mosca also announced that Pacific Rainbow, Inc., City of Industry, CA, a major supplier of raw materials, will be the exclusive U.S. distributor of Celadrin.